{'52WeekChange': -0.44822222,
 'SandP52WeekChange': None,
 'address1': '19900 MacArthur Boulevard',
 'address2': 'Suite 550',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 0.53,
 'askSize': 800,
 'averageDailyVolume10Day': 1049162,
 'averageVolume': 1245815,
 'averageVolume10days': 1049162,
 'beta': 3.97619,
 'beta3Year': None,
 'bid': 0.5034,
 'bidSize': 800,
 'bookValue': 0.731,
 'category': None,
 'circulatingSupply': None,
 'city': 'Irvine',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 0.5086,
 'dayLow': 0.48,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 0.269,
 'enterpriseToRevenue': None,
 'enterpriseValue': -3412975,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 0.5064,
 'fiftyTwoWeekHigh': 1.45,
 'fiftyTwoWeekLow': 0.25,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 11672448,
 'forwardEps': -0.44,
 'forwardPE': -1.144091,
 'fromCurrency': None,
 'fullTimeEmployees': 7,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.045879997,
 'heldPercentInstitutions': 0.35111,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1494460800,
 'lastSplitFactor': '1:9',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/novustherapeutics.com',
 'longBusinessSummary': 'Novus Therapeutics, Inc., a specialty pharmaceutical '
                        'company, focuses on developing products for patients '
                        'with disorders of ear, nose, and throat. Its lead '
                        'product is OP0201, a surfactant-based nasal aerosol '
                        'drug-device combination product for patients at risk '
                        'for, or with, otitis media (OM) (middle ear '
                        'inflammation with or without infection). The company '
                        'also has a foam-based drug delivery technology OP0101 '
                        'and OP0102 that could be used to deliver drugs into '
                        'the ear, nose, and sinus cavities. Novus '
                        'Therapeutics, Inc. is headquartered in Irvine, '
                        'California.',
 'longName': 'Novus Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 8089437,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_62494905',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -19307000,
 'nextFiscalYearEnd': 1640908800,
 'open': 0.49,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.01,
 'phone': '949 238 8090',
 'previousClose': 0.4966,
 'priceHint': 4,
 'priceToBook': 0.6886457,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 0.5086,
 'regularMarketDayLow': 0.48,
 'regularMarketOpen': 0.49,
 'regularMarketPreviousClose': 0.4966,
 'regularMarketPrice': 0.49,
 'regularMarketVolume': 462565,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 16069600,
 'sharesPercentSharesOut': 0.019299999,
 'sharesShort': 309941,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 38913,
 'shortName': 'Novus Therapeutics, Inc.',
 'shortPercentOfFloat': 0.024600001,
 'shortRatio': 0.18,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'NVUS',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.403,
 'twoHundredDayAverage': 0.56691366,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '8848a5d7-52ba-309b-b5aa-5d3c07a804a1',
 'volume': 462565,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://novustherapeutics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92612'}